Finally, four important DEGs (SRC, ARNT, TBP, and SNAI2) were compiled to have distinct effects on the survivals of serous ovarian tumor patients with the help of IHC staining for verification showing elevated expression among all clinical samples with increasing malignancy from serous BOT to early stages and to late stages of serous ovarian carcinomas. This evidence concerns the gene SRC and ovarian serous carcinoma.